îæ€çŽ¢
îæ€çŽ¢
î
Cyclerion Therapeutics Inc
CYCNîãŠã©ãããªã¹ãã«è¿œå
30.430USD
-0.130-0.43%
çµå€Â 09-08 16:00ïŒETïŒ
142.41Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
Cyclerion Therapeutics Incã«ã€ã㊠äŒæ¥å
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.
Cyclerion Therapeutics Inc ãããã£ãŒã«
îäŒæ¥ã³ãŒãCYCN
äŒç€ŸåCyclerion Therapeutics Inc
äžå Žæ¥Mar 18, 2019
æé«çµå¶è²¬ä»»è
ãCEOãGraul (Regina M)
åŸæ¥å¡æ°1
蚌åžçš®é¡Ordinary Share
決ç®ææ«Mar 18
æ¬ç€Ÿæåšå°301 Binney Street
éœåžCAMBRIDGE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·02142
é»è©±çªå·16176217722
ãŠã§ããµã€ãhttps://www.cyclerion.com/
äŒæ¥ã³ãŒãCYCN
äžå Žæ¥Mar 18, 2019
æé«çµå¶è²¬ä»»è
ãCEOãGraul (Regina M)
Cyclerion Therapeutics Incã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
207.40K
+85.71%
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
64.03K
-24.76%
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
7.14K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
4.39K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
2.86K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Rhonda M. Chicko
Ms. Rhonda M. Chicko
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Mark J. Vignola, Ph.D.
Dr. Mark J. Vignola, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Matthew Leoni, M.D.
Dr. Matthew Leoni, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
207.40K
+85.71%
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
64.03K
-24.76%
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
7.14K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
4.39K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
2.86K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
ãããã質å
Cyclerion Therapeutics Incã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îCyclerion Therapeutics Incã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããDr. Jonathan Violin, Ph.D.
Cyclerion Therapeutics IncïŒCYCNïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2026Q1æç¹ã§ãCyclerion Therapeutics Incã®æ ªåŒãä¿æããŠããæ©é¢ã¯37瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ318.08Kã§ãå
šäœã®7.35%ãå ããŠããŸãã2025Q4ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-667233.00å¢å ããŠããŸãã